NEWS: Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC
Data from the LITESPARK-022 study supported adding belzutifan (Welireg) to standard adjuvant pembrolizumab for ...
News Archive
Pembrolizumab
Immunotherapy After Kidney Cancer Surgery Improves Overall Survival
Recently published in the New England Journal of Medicine, findings from the pivotal phase 3 trial, KEYNOTE-564, ...
EMA recommends pembrolizumab for the adjuvant treatment of RCC
Urologytimes.com reports that the European Medicines Agency’s Committee for Medicinal Products for Human Use ...
No results found.